Inge C. van Gool

<i>POLE</i> Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer

Inge C. van Gool, Florine A. Eggink, Luke Freeman-Mills et al. · Clinical Cancer Research · 2015 · 318 citations · Full text

Medicine, Immunology, Oncology +17

A Transcriptionally Distinct CXCL13+CD103+CD8+ T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer

Hagma H. Workel, Joyce M. Lubbers, Roland Arnold et al. · Cancer Immunology Research · 2019 · 262 citations · Full text

Life Sciences, Immunology, Oncology +17

Immunological profiling of molecularly classified high-risk endometrial cancers identifies <i>POLE</i>-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition

Florine A. Eggink, Inge C. van Gool, Alexandra Léary et al. · OncoImmunology · 2016 · 120 citations · Full text

Medicine, Immunology, Oncology +17

Somatic <i>POLE</i> exonuclease domain mutations are early events in sporadic endometrial and colorectal carcinogenesis, determining driver mutational landscape, clonal neoantigen burden and immune response

Daniel Temko, Inge C. van Gool, Emily Rayner et al. · The Journal of Pathology · 2018 · 98 citations · Full text

Medicine, Genetics, Oncology +17

Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancer

Inge C. van Gool, Ellen Stelloo, Remi A. Nout et al. · Modern Pathology · 2016 · 90 citations · Full text

Medicine, Oncology, Pathology +17